Pediatric Inguinal Hernia Repair: Are Muscle Relaxants Necessary? Endotracheal Intubation vs Laryngeal Mask Airway
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02696837 |
Recruitment Status :
Completed
First Posted : March 2, 2016
Last Update Posted : June 1, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Inguinal Hernia Endotracheal Intubation Laryngeal Mask Muscle Relaxants | Device: ETT Device: Proseal LMA Drug: Rocuronium Other: No Muscle Relaxant | Not Applicable |
In this prospective, safety-control study; children undergoing laparoscopic inguinal hernia repair using PIRS (Percutaneous Internal Ring Suturing) method will be randomly assigned into four groups.
Gr 1: Endotracheal intubation and muscle relaxant, Gr 2: Endotracheal Intubation without muscle relaxant, Gr 3: Proseal Laryngeal Mask Airway without muscle relaxant, Gr 4: Proseal Laryngeal Mask Airway with subparalytic does muscle relaxant.
Apart from standard monitorization, all patients' intragastric pressures will also be monitored. Patients' age at presentation, gender, time of surgery, time of anesthesia, intragastric pressure, intraabdominal pressure, intraoperative findings and complications will be noted and compared between groups.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 80 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Official Title: | Safety Control Study in Pediatric Inguinal Hernia Repair: Are Muscle Relaxants Necessary? Endotracheal Intubation vs Laryngeal Mask Airway |
Study Start Date : | March 2016 |
Actual Primary Completion Date : | May 2016 |
Actual Study Completion Date : | May 2016 |
Arm | Intervention/treatment |
---|---|
Active Comparator: ETT & Muscle Relaxant
Children undergoing laparoscopic inguinal hernia repair using PIRS method with Endotracheal Intubation and Muscle Relaxant
|
Device: ETT Drug: Rocuronium |
Active Comparator: ETT & No Muscle Relaxant
Children undergoing laparoscopic inguinal hernia repair using PIRS method with Endotracheal Intubation and No Muscle Relaxant
|
Device: ETT Other: No Muscle Relaxant |
Active Comparator: Proseal LMA & No Muscle Relaxant
Children undergoing laparoscopic inguinal hernia repair using PIRS method with Proseal Laryngeal Mask Airway and NO Muscle Relaxant
|
Device: Proseal LMA Other: No Muscle Relaxant |
Active Comparator: Proseal LMA & Subparalytic Muscle Relaxant
Children undergoing laparoscopic inguinal hernia repair using PIRS method with Proseal Laryngeal Mask Airway and subparalytic dose Muscle Relaxant
|
Device: Proseal LMA Drug: Rocuronium |
- Surgery Time [ Time Frame: Intraoperative ]Time from skin prep to last suture
- Time Under Anesthesia [ Time Frame: Intraoperative ]Time from induction to moderate Alderete score of 9 or above
- Intragastric Pressure [ Time Frame: Intraoperative continuous monitoring ]
- Intraabdominal Pressure [ Time Frame: Intraoperative continuous monitoring ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children aged 0-18 years
- Diagnosed with inguinal hernia or communicating hydrocele
- Due to undergo laparoscopic inguinal hernia repair
Exclusion Criteria:
- Previous abdominal surgery
- Comorbidities that will effect surgical time, time under anesthesia, intragastric pressure and abdominal pressure

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02696837
Turkey | |
Maltepe University Hospital | |
Istanbul, Turkey |
Principal Investigator: | Serkan Tulgar, M.D. | Maltepe University |
Other Publications:
Responsible Party: | Asst. Prof. Serkan Tulgar, M.D., Principle Investigator, Maltepe University |
ClinicalTrials.gov Identifier: | NCT02696837 |
Other Study ID Numbers: |
PIRS002 |
First Posted: | March 2, 2016 Key Record Dates |
Last Update Posted: | June 1, 2016 |
Last Verified: | May 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Muscle Hypotonia Hernia Hernia, Inguinal Pathological Conditions, Anatomical Hernia, Abdominal Neuromuscular Manifestations Neurologic Manifestations |
Nervous System Diseases Rocuronium Neuromuscular Nondepolarizing Agents Neuromuscular Blocking Agents Neuromuscular Agents Peripheral Nervous System Agents Physiological Effects of Drugs |